secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K
Filed at:   2025-07-07T23:59:59+00:00
Accession:  0001612630-25-000009
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

The Joint Corp. closes sale of 31 clinics for $11.13M, acquires NW region RD rights
--------------------------------------------------------------------------------

- Sold 31 company-owned clinics in AZ/NM to Joint Ventures, LLC for $11.13M (includes $8.3M cash).
- Acquired regional developer rights for Northwest region (46 franchised clinics, 30 future sites).
- Acquired RD rights generated $855,000 in royalties/fees in trailing 12 months ended March 31, 2025.
- Pro forma shows net income from continuing operations of $88,979 for Q1 2025 vs prior loss of $506,021.
- Transaction expected to reduce commission obligations and increase operating margin.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000161263025000009/0001612630-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000161263025000009/jynt-20250630.htm
  HTML page:      https://secwatch.observer/filing/0001612630-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer